Search research articles
Contact Us
Filters
Showing results (61-70 of 145) with videos related to
Page
of 15
Sort By:
Blood
|
January 10, 2008
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group
Stella M Davies, Michael J Borowitz, Gary L Rosner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study
Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Blood
|
May 6, 2010
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group
Kelly W Maloney, William L Carroll, Andrew J Carroll, et al.
Blood
|
June 12, 2012
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
Sarah K Tasian, Michelle Y Doral, Michael J Borowitz, et al.
Blood
|
April 5, 2008
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J Borowitz, Meenakshi Devidas, Stephen P Hunger, et al.
Haematologica
|
February 1, 2020
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433
Glen Lew, Yichen Chen, Xiaomin Lu, et al.
Blood
|
July 11, 2006
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Deepa Bhojwani, Huining Kang, Naomi P Moskowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2013
Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities
Matthew P Tilson, Richard J Jones, Amy Sexauer, et al.
Archives of Pathology & Laboratory Medicine
|
February 23, 2017
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology
Daniel A Arber, Michael J Borowitz, Melissa Cessna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
Nicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 145) with videos related to
Sort By:
Page
of 15
Blood
|
January 10, 2008
Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group
Stella M Davies, Michael J Borowitz, Gary L Rosner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2008
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study
Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
Blood
|
May 6, 2010
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group
Kelly W Maloney, William L Carroll, Andrew J Carroll, et al.
Blood
|
June 12, 2012
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
Sarah K Tasian, Michelle Y Doral, Michael J Borowitz, et al.
Blood
|
April 5, 2008
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J Borowitz, Meenakshi Devidas, Stephen P Hunger, et al.
Haematologica
|
February 1, 2020
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433
Glen Lew, Yichen Chen, Xiaomin Lu, et al.
Blood
|
July 11, 2006
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Deepa Bhojwani, Huining Kang, Naomi P Moskowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 18, 2013
Targeted pathologic evaluation of bone marrow donors identifies previously undiagnosed marrow abnormalities
Matthew P Tilson, Richard J Jones, Amy Sexauer, et al.
Archives of Pathology & Laboratory Medicine
|
February 23, 2017
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology
Daniel A Arber, Michael J Borowitz, Melissa Cessna, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies
Nicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Page
of 15